Ketamine activates psychosis and alters limbic blood flow in schizophrenia.
about
GABAergic interneuron origin of schizophrenia pathophysiology.Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortexAnimal models of schizophrenia: a critical reviewFunctional neuroimaging in psychiatryRIM1alpha and interacting proteins involved in presynaptic plasticity mediate prepulse inhibition and additional behaviors linked to schizophreniaIntravenous sub-anesthetic ketamine for perioperative analgesiaPositive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatmentGABA abnormalities in schizophrenia: a methodological review of in vivo studiesThe role of glutamatergic inputs onto parvalbumin-positive interneurons: relevance for schizophreniaEmotional and cognitive dysregulation in schizophrenia and depression: understanding common and distinct behavioral and neural mechanismsDrug models of schizophreniaJumping to conclusions in schizophreniaEffects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA-, alpha(1)- and 5-HT(2A)-receptorsRemoving obstacles in neuroscience drug discovery: the future path for animal models.Impaired prefrontal synaptic gain in people with psychosis and their relatives during the mismatch negativity.Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice.How Nox2-containing NADPH oxidase affects cortical circuits in the NMDA receptor antagonist model of schizophrenia.Deficits in emotional learning and memory in an animal model of schizophreniaMismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.Is the acute NMDA receptor hypofunction a valid model of schizophrenia?Prefrontal function at presentation directly related to clinical outcome in people at ultrahigh risk of psychosis.Brain mechanisms of hallucinogens and entactogens.Effect of amphetamine on extracellular concentrations of amino acids in striatum in neurotensin subtype 1 and 2 receptor null mice: a possible interaction between neurotensin receptors and amino acid systems for study of schizophrenia.The functional neuroanatomy of symptom dimensions in schizophrenia: a qualitative and quantitative review of a persistent question.Reduced NMDAR1 expression in the Sp4 hypomorphic mouse may contribute to endophenotypes of human psychiatric disordersTypical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction.MRI anatomy of schizophrenia.Glutamate and its receptors in the pathophysiology and treatment of major depressive disorderGlutamate-mediated excitotoxicity in schizophrenia: a review.Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology.Limbic structures and networks in children and adolescents with schizophrenia.Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.The interactive effects of ketamine and nicotine on human cerebral blood flowNMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons.Development of allosteric modulators of GPCRs for treatment of CNS disordersNMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex.Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamineEarly-course unmedicated schizophrenia patients exhibit elevated prefrontal connectivity associated with longitudinal change.Pharmacotherapy for treatment-resistant schizophrenia.Role of Thalamic Projection in NMDA Receptor-Induced Disruption of Cortical Slow Oscillation and Short-Term Plasticity.
P2860
Q24597790-C4C6CD95-A740-4272-9547-76BE67F668DBQ24602550-EDC37E43-D082-43ED-9F37-F4C7742D8937Q24674909-4C62E928-75F2-4A24-95A4-F50B7E5B3B10Q24676567-D79129F8-8C02-424C-B2C7-0700FC157557Q26269908-293A0F4A-E926-4C61-BA79-9CE914B366C5Q26747577-B08DA463-1AE4-48D6-B6DF-6194A4142C22Q26852047-A3C9A273-C675-43A7-860F-60C6648D1A1FQ26864125-D408A539-F44B-41BD-A6D7-8C0F5E26CD1FQ27023087-E1DEFB67-60A2-4D7E-AD92-69019BBC36EFQ28073684-FDE5CDD2-B6B6-453E-B10C-051AE7B3C1E4Q28084198-33C7389E-E822-467C-8180-507F76BEABE1Q28087488-81630347-A1DC-453B-AFB5-CE4B36E1D883Q28344844-4251DDDF-6174-44C9-994E-D6B2FD639B2BQ28755229-919766EA-26D5-480A-9B78-8B33BE025A71Q30384905-22051EBD-A984-4EB6-A454-BEB52B7A1C59Q30403787-CBD40471-7A1A-4544-8AE2-0EA60D3006B2Q30439924-57EB0DDE-D7EA-4AD3-8A67-E1CEC6C2D6FEQ30452228-377B015D-091C-45FE-9286-B26FC1BC62AFQ30457813-20C1A22D-A464-49C8-B224-9656CD848057Q30459655-FAA71269-5FE0-4B0A-BCDB-7589F1777A85Q30471857-59DE851C-F8B5-44AC-B6A7-9B102E09F303Q30473430-7A04BF14-0D55-49BA-AC69-17BA5FDD60D9Q30475349-B29C4BFB-6E5F-449C-8577-A1E50C1DD5BDQ30477381-AEC1916F-274E-40B8-A87E-E73C2359A19AQ30496492-64186AC2-508F-4255-A73B-E31932B618B1Q30498942-7B78DA54-49AF-469E-B498-CBB180C0D977Q30577334-51E47FE6-98B7-4A27-8615-71946A917BB9Q30711088-30AEF100-EF67-4C78-B32D-BFD8FDBC818FQ30845062-FB6569C1-0761-4BE9-9FB6-7F5F822DBF37Q31153621-68ABA97A-D20D-4752-AC42-E487E9C66F77Q33302997-B920B259-7D7D-4AB4-87AD-E7AF085114C6Q33874459-21ECDD5E-54A8-4526-B424-B460F77A7B0CQ33937889-66B66F80-C472-4FD6-A6ED-A7D80EA98F56Q34197064-CD969FA4-0782-41E9-805F-D7CF99F81197Q34373958-6545F69F-C01D-432F-9637-90D2D74FB8A7Q34376159-E9D74CEE-75AC-497A-9E8D-1C3046494C34Q34661613-5CA185D3-61D1-4471-8D8B-285DA93918A8Q34869701-0B79A8BA-8439-4D19-A7BB-CBF737361D1EQ34879109-A255AD6A-0065-4A0D-AF6E-CF4FF0F5065BQ34953049-6DF4681B-8BD9-4C4C-AAAE-73A205EECFEF
P2860
Ketamine activates psychosis and alters limbic blood flow in schizophrenia.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Ketamine activates psychosis and alters limbic blood flow in schizophrenia.
@ast
Ketamine activates psychosis and alters limbic blood flow in schizophrenia.
@en
type
label
Ketamine activates psychosis and alters limbic blood flow in schizophrenia.
@ast
Ketamine activates psychosis and alters limbic blood flow in schizophrenia.
@en
prefLabel
Ketamine activates psychosis and alters limbic blood flow in schizophrenia.
@ast
Ketamine activates psychosis and alters limbic blood flow in schizophrenia.
@en
P2093
P1433
P1476
Ketamine activates psychosis and alters limbic blood flow in schizophrenia
@en
P2093
C A Tamminga
D R Medoff
H H Holcomb
P304
P356
10.1097/00001756-199504190-00011
P577
1995-04-01T00:00:00Z